Recombinant E. coli for Defined PHA Polymer Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling the repeating unit composition of medium-chain-length (MCL) poly(3-hydroxyalkanoate) (PHA) biopolymers are limited, resulting in uncontrollable random mixtures of repeating units with varying side chain lengths, and previous attempts to control MCL PHA synthesis in native or recombinant organisms have restricted ranges.
Innovation Solution
A recombinant Escherichia coli system is developed, where the fadB and fadJ genes are deleted from the β-oxidation pathway, allowing (R)-specific enoyl-CoA hydratase and PHA synthase enzymes to convert fatty acid substrates into PHAs with defined repeating units, enabling precise control over the composition of PHA polymers by selecting substrates of equal carbon length.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used to control MCL PHA synthesis in native or recombinant organisms, then some control over repeating units is achieved, but the control range is limited to only a couple of repeating units and control is lost when carbons exceed seven
Solution Approach 1:
The invention segments the β-oxidation pathway by deleting specific genes (fadB, fadJ, fadR) to create discrete metabolic blocks. This segmentation prevents the formation of mixed-length repeating units and enables precise control over the carbon chain length of PHA repeating units by selecting substrates with specific carbon lengths, thereby achieving both precision and versatility.
Solution Approach 2:
The invention changes the metabolic parameters of E. coli by deleting genes encoding enzymes in the β-oxidation pathway. This parameter change (gene deletion) fundamentally alters the metabolic flow to prevent random mixture formation, enabling the production of MCL PHAs with defined repeating unit compositions across a broad range of carbon lengths (4-12 carbons).
2Quantity of substance
If MCL PHA synthesis is attempted in native organisms, then some PHA production is achieved, but the composition becomes an uncontrollable random mixture of repeating units with differing side chain lengths
Solution Approach 1:
The invention extracts or removes the problematic β-oxidation pathway enzymes from E. coli by deleting the fadB, fadJ, and fadR genes. This extraction eliminates the source of random mixture formation while preserving the ability to produce PHA from fatty acid substrates, thereby achieving both production and compositional uniformity.
Solution Approach 2:
The invention introduces an intermediary mechanism where fatty acid substrates with specific carbon lengths are directly converted to PHA repeating units of corresponding lengths through the modified metabolic pathway. This intermediary approach ensures that the composition of the final PHA product directly reflects the composition of the input substrates, providing controllable uniformity.
3Manufacturing precision
If the β-oxidation pathway is blocked to achieve repeating unit control, then defined repeating unit composition is achieved, but the system requires genetic modification of the organism
Solution Approach 1:
The invention performs preliminary genetic modification by deleting the β-oxidation pathway genes (fadB, fadJ, fadR) before PHA production. This preliminary action creates a pre-configured metabolic system that naturally produces defined repeating unit compositions without requiring additional complex control mechanisms during the production process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the production of PHA polymers with strict control over repeating unit composition, achieving unprecedented control from four to twelve carbons in length, enabling the synthesis of homopolymers and copolymers with desired physical properties for various applications, including medical uses.
Implementation Method 1
expresses an (R)-specific enoyl-CoA hydratase and a PHA synthase
Implementation Method 2
PHA synthase enzymes to convert fatty acid substrates into PHAs with defined repeating units
Data Source
AI summary
Methods and systems for producing prescribed unit size poly(3-hydroxyalkanoate) (PHA) polymers and copolymers are provided. The methods and systems can employ recombinant bacteria that are not native producers of PHA or lack enzymes to degrade PHA once synthesized, metabolize short to long chain fatty acids without induction, and express an (R)-specific enoyl-CoA hydratase and a PHA synthase, the (R)-specific enoyl-CoA hydratase and PHA synthase having wide substrate specificities. The recombinant bacteria are fed at least one fatty acid substrate that is equal in carbon length to the prescribed or desired unit size of the PHA polymer to be produced. The prescribed unit size PHA that is produced is then isolated and/or purified.